Company: MVIS
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021931
Chunk: 151

Company: MICROVISION, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 151
---
 interest rate 
     3.65% 
     4.18%
  
    Dividend yield 
     0% 
     0%
  
    Volatility 
     89.14% 
     78.02%
  
    Discount rate 
     50.0% 
     50.0%

7.
WARRANT LIABILITY

On
February 3, 2025, the Company entered into a new Securities Purchase Agreement (the “2025 Purchase Agreement”) with an institutional
investor. In exchange for $8.0 million, the Holder agreed to purchase 5,750,225 shares of common stock (the “closing shares”)
and warrants to purchase up to 5,750,225 shares of common stock at an exercise price of $1.57 per share (the “warrants”).
On February 4, 2025, the 2025 Purchase Agreement closed for net proceeds of approximately $7.8 million, inclusive of all fees and expenses
related to the transaction. The warrants are exercisable beginning August 4, 2025 and expire on August 4, 2030. There have been no exercises
of warrants as of September 30, 2025.

The
warrants are accounted for as a liability under ASC 480, Distinguishing Liabilities from Equity. Both the closing shares and the warrants
are initially recorded on February 4, 2025 at their fair values of $9.0 million and $6.3 million, respectively. The warrant liability
is subsequently remeasured and reported at fair value each reporting period, with the changes in fair value recorded as an unrealized
gain or loss and recognized in earnings.

The
fair value of warrants as of September 30, 2025 and December 31, 2024 are as follows:

 SCHEDULE
OF FAIR VALUE OF WARRANTS

    September 30,  
    December 31, 
  
    (in thousands) 
    2025  
    2024 
  
    Warrant liability 
    $4,059  
    $- 
  
    Total 
    $4,059  
    $- 

Unrealized
gains and losses associated with warrants are as follows:

 SCHEDULE
OF UNREALIZED GAINS AND LOSSES ASSOCIATED WITH WARRANTS

    (in thousands) 
    2025  
    2024  
    2025